| Name |
|---|
BISPR GeneBST2 interferon stimulated positive regulator (non-protein coding) |
TESPA1 Genethymocyte expressed, positive selection associated 1 Predicted to enable phospholipase binding activity and signaling receptor binding activity. Predicted to be involved in COP9 signalosome assembly; positive regulation of T cell differentiation in thymus; and positive regulation of T cell receptor signaling pathway. Predicted to act upstream of or within TCR signalosome assembly. Located in cytosol. Part of COP9 signalosome. [provided by Alliance of Genome Resources, Mar 2025] |
GAPLINC Genegastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA |
MDCMP Genemuscular dystrophy, congenital, merosin-positive |
GREB1L Genegrowth regulation by estrogen in breast cancer-like Acts upstream of or within kidney development. Predicted to be located in membrane. Implicated in autosomal dominant nonsyndromic deafness 80 and renal agenesis. [provided by Alliance of Genome Resources, Mar 2025] |
RPRD1A Generegulation of nuclear pre-mRNA domain containing 1A This gene encodes a cell-cycle and transcription regulatory protein. The encoded protein interacts with the cell cycle inhibitor cyclin-dependent kinase 4 inhibitor B and may function as a negative regulator of G(1)/S phase progression. This protein also forms homo- and hetrodimers with the protein, regulation of nuclear pre-mRNA domain-containing protein 1B, to form a scaffold that interacts with the C-terminal domain of RNA polymerase II subunit B1 and regulates several aspects of transcription. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 16. [provided by RefSeq, Dec 2014] |
RPRD1B Generegulation of nuclear pre-mRNA domain containing 1B Enables RNA polymerase II complex binding activity and identical protein binding activity. Involved in several processes, including RNA polymerase II promoter clearance; positive regulation of cell population proliferation; and positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. Part of transcription preinitiation complex. [provided by Alliance of Genome Resources, Mar 2025] |
RPRD2 Generegulation of nuclear pre-mRNA domain containing 2 Predicted to enable RNA polymerase II complex binding activity. Predicted to be involved in mRNA 3'-end processing. Part of transcription preinitiation complex. [provided by Alliance of Genome Resources, Mar 2025] |
GREB1 Genegrowth regulation by estrogen in breast cancer 1 This gene is an estrogen-responsive gene that is an early response gene in the estrogen receptor-regulated pathway. It is thought to play an important role in hormone-responsive tissues and cancer. Three alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008] |
LOC100130602 Generegulation of nuclear pre-mRNA domain containing 1A pseudogene |
PELATON Geneplaque enriched lncRNA in atherosclerotic and inflammatory bowel macrophage regulation |
PRAL Genep53 regulation associated lncRNA |
MNDEC GeneMicrotia with nasolacrimal duct imperforation and eye coloboma |
CECR5 Genecat eye syndrome chromosome region, candidate 5 Predicted to be involved in glycerophospholipid biosynthetic process. Located in mitochondrion. [provided by Alliance of Genome Resources, Mar 2025] |
CECR9 Genecat eye syndrome chromosome region, candidate 9 (non-protein coding) Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Mar 2025] |
BED GeneBornholm eye disease |
OED GeneOregon eye disease |
CECR1 Genecat eye syndrome chromosome region, candidate 1 This gene encodes a member of a subfamily of the adenosine deaminase protein family. The encoded protein is one of two adenosine deaminases found in humans, which regulate levels of the signaling molecule, adenosine. The encoded protein is secreted from monocytes undergoing differentiation and may regulate cell proliferation and differentiation. This gene may be responsible for some of the phenotypic features associated with cat eye syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013] |
CECR2 Genecat eye syndrome chromosome region, candidate 2 This gene encodes a bromodomain-containing protein that is involved in chromatin remodeling, and may additionally play a role in DNA damage response. The encoded protein functions as part of an ATP-dependent complex that is involved in neurulation. This gene is a candidate gene for Cat Eye Syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014] |
CECR3 Genecat eye syndrome chromosome region, candidate 3 (non-protein coding) |
CECR6 Genecat eye syndrome chromosome region, candidate 6 |
EYCL1 Geneeye color 1 (green/blue) |
SHEP8 GeneSkin/hair/eye pigmentation 8, freckling |
CECR7 Genecat eye syndrome chromosome region, candidate 7 (non-protein coding) |
CECR Genecat eye syndrome chromosome region Cat eye syndrome (CES) is characterized clinically by the combination of coloboma of the iris and anal atresia with fistula, downslanting palpebral fissures, preauricular tags and/or pits, frequent occurrence of heart and renal malformations, and normal or near-normal mental development. A small supernumerary chromosome (smaller than chromosome 21) is present, frequently has 2 centromeres, is bisatellited, and represents an inv dup(22)(q11).[supplied by OMIM, Aug 2009] |